Helicobacter pylori infection
Conditions
Interventions
Group 1 :taking dual therapy continuously for 10 days
Group 2:taking dual therapy continuously for 14 days
Sponsors
Department of Gastroenterology, Peking University Third Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients over 18 years; 2. UBT should be positive, and the eradication therapy is needed by the opnion of doctor; 3. The informed consent is signed.
Exclusion criteria
Exclusion criteria: 1. Suffering from Zuo-AI syndrome or excessive gastric acid secretion; 2. Previous Hp eradication treatment; 3. Has undergone major surgery or plans to undergo surgery that may affect gastric acid secretion within 30 days prior to the screening visit, or is not suitable for medication for other reasons; 4. Received antibiotics, bismuth, acid suppressive drugs within 4 weeks; 5. History of hypersensitivity or allergy to vonorazine or amoxicillin; 6. Being treated with azanavir or ripiavirin; 7. Abnormal liver and kidney function; 8. Female subjects are pregnant or lactating; 9. Having other serious medical conditions; 10. A history of alcohol abuse, illicit drug use or drug addiction in the 12 months prior to screening; 11. You need to take prohibited drugs; 12. Subjects were participating in another clinical study at the time of enrollment in this study; 13. History of malignancy; 14. Has a known acquired immune deficiency syndrome.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| urea breath test; | — |
Countries
China
Contacts
Public ContactZhou Liya
Peking University Third Hospital
Outcome results
None listed